Mianserin (Bolvidon; Norval) has been available for about 10 years, but its place in the treatment of depression remains unclear. It has become particularly popular for use in elderly depressed patients. However, its safety and efficacy compared to older tricyclic antidepressives is not clearly established.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.